ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,456Medicare Part D Prescriptions Filled, Including Refills

Rank: 83 out of 288

$480K Total Retail Price of All Prescriptions

Rank: 81 out of 288

354 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
13% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 354 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 354 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 8,268 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
SIMVASTATIN 533 505 1 1
AMLODIPINE BESYLATE 425 406 2 6
LEVOTHYROXINE SODIUM 339 298 3 2
LISINOPRIL 311 285 4 4
OMEPRAZOLE 288 272 5 3
HYDROCODONE-ACETAMINOPHEN 275 198 S3 6 7
ATORVASTATIN CALCIUM 225 205 7 14
HYDROCHLOROTHIAZIDE 211 210 8 13
METFORMIN HCL 172 146 9 12
ZOLPIDEM TARTRATE 171 150 10 22
ATENOLOL 164 158 11 10
FUROSEMIDE 161 144 12 5
TRIAMTERENE-HCTZ 158 152 13 28
LOSARTAN POTASSIUM 146 140 14 16
ALENDRONATE SODIUM 142 137 15 20
METOPROLOL SUCCINATE 141 139 16 15
CITALOPRAM HBR 136 125 17 18
POTASSIUM CHLORIDE 135 129 18 11
METOPROLOL TARTRATE 135 95 18 8
TAMSULOSIN HCL 129 109 20 24
DIOVAN 112 111 21 53
GABAPENTIN 105 85 22 17
NEXIUM 104 53 23 43
CRESTOR 100 73 24 26
WARFARIN SODIUM 100 100 24 9
PANTOPRAZOLE SODIUM 99 70 26 42
PRAVASTATIN SODIUM 98 92 27 21
GLYBURIDE 96 85 R 28 59
FLUTICASONE PROPIONATE 93 86 29 41
SPIRONOLACTONE 93 82 29 36
GEMFIBROZIL 90 54 31 77
ALLOPURINOL 87 75 32 23
NAMENDA 86 86 33 39
PAROXETINE HCL 82 81 34 54
SYNTHROID 72 72 35 63
CYCLOBENZAPRINE HCL 71 49 R 36 73
PEN NEEDLE 69 59 37 100
DONEPEZIL HCL 65 65 38 29
TRAMADOL HCL 62 55 39 19
HUMALOG 61 42 40 117
LANTUS SOLOSTAR 59 54 41 81
CLONIDINE HCL 57 57 42 70
DIOVAN HCT 56 56 43 112
LOSARTAN-HYDROCHLOROTHIAZIDE 55 55 44 55
VERAPAMIL ER 55 55 44 97
LISINOPRIL-HYDROCHLOROTHIAZIDE 55 51 44 34
PREMARIN 50 39 R 47 143
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 17, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.